APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaccine Adjuvants

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

Selected research

Industry Growth & Trends

Global Vaccine Adjuvants Industry Growth and Trends Forecast to 2032

25 December 2025112 pages

Choose your research edition.

Industry ResearchVaccine Adjuvants Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccine Adjuvants Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Vaccine Adjuvants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccine Adjuvants Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccine Adjuvants Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

The top 5 global manufacturers of vaccine adjuvants are GSK, CSL Limited, Croda, SEPPIC, Novavax, which have a combined market share of about 55 percent. North America is the largest market, with a share about 38%, followed by Europe and Asia Pacific with the share about 27% and 22%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Vaccine Adjuvants market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vaccine Adjuvants market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vaccine Adjuvants market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vaccine Adjuvants.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Vaccine Adjuvants market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vaccine Adjuvants Market by Company

GSK

CSL Limited

Croda

SEPPIC

Novavax

SPI Pharma

Phibro

SDA BIO

Invivogen

Tj Kaiwei

OZ Biosciences

Brenntag Biosector

MVP Laboratories

Zhuoyue

Aphios

Vaccine Adjuvants Segment by Type

Aluminum Adjuvant

Emulsions Adjuvant

Others

Vaccine Adjuvants Segment by Application

Human Vaccine

Veterinary Vaccine

Vaccine Adjuvants Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccine Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Adjuvants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vaccine Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Vaccine Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Aluminum Adjuvant Table 2. Major Company of Emulsions Adjuvant Table 3. Major Company of Others Table 4. Global Vaccine Adjuvants Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Vaccine Adjuvants Sales by Type (2021-2026) & (MT) Table 6. Global Vaccine Adjuvants Sales Market Share in Volume by Type (2021-2026) Table 7. Global Vaccine Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 8. Global Vaccine Adjuvants Sales Market Share in Value by Type (2021-2026) Table 9. Global Vaccine Adjuvants Price by Type (2021-2026) & (USD/Kg) Table 10. Global Vaccine Adjuvants Sales by Type (2027-2032) & (MT) Table 11. Global Vaccine Adjuvants Sales Market Share in Volume by Type (2027-2032) Table 12. Global Vaccine Adjuvants Sales by Type (2027-2032) & (US$ Million) Table 13. Global Vaccine Adjuvants Sales Market Share in Value by Type (2027-2032) Table 14. Global Vaccine Adjuvants Price by Type (2027-2032) & (USD/Kg) Table 15. North America Vaccine Adjuvants Sales by Type (2021-2026) & (MT) Table 16. North America Vaccine Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Vaccine Adjuvants Sales by Type (2021-2026) & (MT) Table 18. Europe Vaccine Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Vaccine Adjuvants Sales by Type (2021-2026) & (MT) Table 20. Asia-Pacific Vaccine Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Vaccine Adjuvants Sales by Type (2021-2026) & (MT) Table 22. Latin America Vaccine Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Vaccine Adjuvants Sales by Type (2021-2026) & (MT) Table 24. Middle East and Africa Vaccine Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 25. Vaccine Adjuvants Industry Trends Table 26. Vaccine Adjuvants Industry Drivers Table 27. Vaccine Adjuvants Industry Opportunities and Challenges Table 28. Vaccine Adjuvants Industry Restraints Table 29. Global Vaccine Adjuvants Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Vaccine Adjuvants Revenue Market Share by Company (2021-2026) Table 31. Global Vaccine Adjuvants Sales by Company (2021-2026) & (MT) Table 32. Global Vaccine Adjuvants Sales Share by Company (2021-2026) Table 33. Global Vaccine Adjuvants Market Price by Company (2021-2026) & (USD/Kg) Table 34. Global Vaccine Adjuvants Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Vaccine Adjuvants Major Company Production Sites and Headquarters Table 36. Global Vaccine Adjuvants Company, Product Type & Application Table 37. Global Vaccine Adjuvants Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Vaccine Adjuvants Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Vaccine Adjuvants Sales by Region (2021-2026) & (MT) Table 42. Global Vaccine Adjuvants Sales Market Share in Volume by Region (2021-2026) Table 43. Global Vaccine Adjuvants Sales by Region (2021-2026) & (US$ Million) Table 44. Global Vaccine Adjuvants Sales Market Share in Value by Region (2021-2026) Table 45. Global Vaccine Adjuvants Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 46. Global Vaccine Adjuvants Sales by Region (2027-2032) & (MT) Table 47. Global Vaccine Adjuvants Sales Market Share in Volume by Region (2027-2032) Table 48. Global Vaccine Adjuvants Sales by Region (2027-2032) & (US$ Million) Table 49. Global Vaccine Adjuvants Sales Market Share in Value by Region (2027-2032) Table 50. Global Vaccine Adjuvants Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2027-2032) Table 51. Global Vaccine Adjuvants Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Vaccine Adjuvants Sales by Application (2021-2026) & (MT) Table 53. Global Vaccine Adjuvants Sales Market Share in Volume by Application (2021-2026) Table 54. Global Vaccine Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 55. Global Vaccine Adjuvants Sales Market Share in Value by Application (2021-2026) Table 56. Global Vaccine Adjuvants Price by Application (2021-2026) & (USD/Kg) Table 57. Global Vaccine Adjuvants Sales by Application (2027-2032) & (MT) Table 58. Global Vaccine Adjuvants Sales Market Share in Volume by Application (2027-2032) Table 59. Global Vaccine Adjuvants Sales by Application (2027-2032) & (US$ Million) Table 60. Global Vaccine Adjuvants Sales Market Share in Value by Application (2027-2032) Table 61. Global Vaccine Adjuvants Price by Application (2027-2032) & (USD/Kg) Table 62. North America Vaccine Adjuvants Sales by Application (2021-2026) & (MT) Table 63. North America Vaccine Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Vaccine Adjuvants Sales by Application (2021-2026) & (MT) Table 65. Europe Vaccine Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Vaccine Adjuvants Sales by Application (2021-2026) & (MT) Table 67. Asia-Pacific Vaccine Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Vaccine Adjuvants Sales by Application (2021-2026) & (MT) Table 69. Latin America Vaccine Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Vaccine Adjuvants Sales by Application (2021-2026) & (MT) Table 71. Middle East and Africa Vaccine Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 72. GSK Company Information Table 73. GSK Business Overview Table 74. GSK Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 75. GSK Vaccine Adjuvants Product Portfolio Table 76. GSK Recent Development Table 77. CSL Limited Company Information Table 78. CSL Limited Business Overview Table 79. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 80. CSL Limited Vaccine Adjuvants Product Portfolio Table 81. CSL Limited Recent Development Table 82. Croda Company Information Table 83. Croda Business Overview Table 84. Croda Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 85. Croda Vaccine Adjuvants Product Portfolio Table 86. Croda Recent Development Table 87. SEPPIC Company Information Table 88. SEPPIC Business Overview Table 89. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 90. SEPPIC Vaccine Adjuvants Product Portfolio Table 91. SEPPIC Recent Development Table 92. Novavax Company Information Table 93. Novavax Business Overview Table 94. Novavax Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 95. Novavax Vaccine Adjuvants Product Portfolio Table 96. Novavax Recent Development Table 97. SPI Pharma Company Information Table 98. SPI Pharma Business Overview Table 99. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 100. SPI Pharma Vaccine Adjuvants Product Portfolio Table 101. SPI Pharma Recent Development Table 102. Phibro Company Information Table 103. Phibro Business Overview Table 104. Phibro Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 105. Phibro Vaccine Adjuvants Product Portfolio Table 106. Phibro Recent Development Table 107. SDA BIO Company Information Table 108. SDA BIO Business Overview Table 109. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 110. SDA BIO Vaccine Adjuvants Product Portfolio Table 111. SDA BIO Recent Development Table 112. Invivogen Company Information Table 113. Invivogen Business Overview Table 114. Invivogen Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 115. Invivogen Vaccine Adjuvants Product Portfolio Table 116. Invivogen Recent Development Table 117. Tj Kaiwei Company Information Table 118. Tj Kaiwei Business Overview Table 119. Tj Kaiwei Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 120. Tj Kaiwei Vaccine Adjuvants Product Portfolio Table 121. Tj Kaiwei Recent Development Table 122. OZ Biosciences Company Information Table 123. OZ Biosciences Business Overview Table 124. OZ Biosciences Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 125. OZ Biosciences Vaccine Adjuvants Product Portfolio Table 126. OZ Biosciences Recent Development Table 127. Brenntag Biosector Company Information Table 128. Brenntag Biosector Business Overview Table 129. Brenntag Biosector Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 130. Brenntag Biosector Vaccine Adjuvants Product Portfolio Table 131. Brenntag Biosector Recent Development Table 132. MVP Laboratories Company Information Table 133. MVP Laboratories Business Overview Table 134. MVP Laboratories Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 135. MVP Laboratories Vaccine Adjuvants Product Portfolio Table 136. MVP Laboratories Recent Development Table 137. Zhuoyue Company Information Table 138. Zhuoyue Business Overview Table 139. Zhuoyue Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 140. Zhuoyue Vaccine Adjuvants Product Portfolio Table 141. Zhuoyue Recent Development Table 142. Aphios Company Information Table 143. Aphios Business Overview Table 144. Aphios Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 145. Aphios Vaccine Adjuvants Product Portfolio Table 146. Aphios Recent Development Table 147. North America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 148. North America Vaccine Adjuvants Sales by Country (2021-2026) & (MT) Table 149. North America Vaccine Adjuvants Sales Market Share by Country (2021-2026) Table 150. North America Vaccine Adjuvants Sales Forecast by Country (2027-2032) & (MT) Table 151. North America Vaccine Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 152. North America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. North America Vaccine Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 154. North America Vaccine Adjuvants Market Share by Country (2021-2026) Table 155. North America Vaccine Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. North America Vaccine Adjuvants Market Share Forecast by Country (2027-2032) Table 157. Europe Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 158. Europe Vaccine Adjuvants Sales by Country (2021-2026) & (MT) Table 159. Europe Vaccine Adjuvants Sales Market Share by Country (2021-2026) Table 160. Europe Vaccine Adjuvants Sales Forecast by Country (2027-2032) & (MT) Table 161. Europe Vaccine Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 162. Europe Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Europe Vaccine Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 164. Europe Vaccine Adjuvants Market Share by Country (2021-2026) Table 165. Europe Vaccine Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Europe Vaccine Adjuvants Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Vaccine Adjuvants Sales by Country (2021-2026) & (MT) Table 169. Asia-Pacific Vaccine Adjuvants Sales Market Share by Country (2021-2026) Table 170. Asia-Pacific Vaccine Adjuvants Sales Forecast by Country (2027-2032) & (MT) Table 171. Asia-Pacific Vaccine Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 172. Asia-Pacific Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Asia-Pacific Vaccine Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 174. Asia-Pacific Vaccine Adjuvants Market Share by Country (2021-2026) Table 175. Asia-Pacific Vaccine Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Asia-Pacific Vaccine Adjuvants Market Share Forecast by Country (2027-2032) Table 177. Latin America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 178. Latin America Vaccine Adjuvants Sales by Country (2021-2026) & (MT) Table 179. Latin America Vaccine Adjuvants Sales Market Share by Country (2021-2026) Table 180. Latin America Vaccine Adjuvants Sales Forecast by Country (2027-2032) & (MT) Table 181. Latin America Vaccine Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 182. Latin America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Latin America Vaccine Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 184. Latin America Vaccine Adjuvants Market Share by Country (2021-2026) Table 185. Latin America Vaccine Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Latin America Vaccine Adjuvants Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Vaccine Adjuvants Sales by Country (2021-2026) & (MT) Table 189. Middle East and Africa Vaccine Adjuvants Sales Market Share by Country (2021-2026) Table 190. Middle East and Africa Vaccine Adjuvants Sales Forecast by Country (2027-2032) & (MT) Table 191. Middle East and Africa Vaccine Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 192. Middle East and Africa Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Middle East and Africa Vaccine Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 194. Middle East and Africa Vaccine Adjuvants Market Share by Country (2021-2026) Table 195. Middle East and Africa Vaccine Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Middle East and Africa Vaccine Adjuvants Market Share Forecast by Country (2027-2032) Table 197. Key Raw Materials Table 198. Raw Materials Key Suppliers Table 199. Vaccine Adjuvants Distributors List Table 200. Vaccine Adjuvants Customers List Table 201. Research Programs/Design for This Report Table 202. Authors List of This Report Table 203. Secondary Sources Table 204. Primary Sources List of Figures Figure 1. Vaccine Adjuvants Image Figure 2. Global Vaccine Adjuvants Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccine Adjuvants Market Size (2021-2032) & (US$ Million) Figure 4. Global Vaccine Adjuvants Sales (2021-2032) & (MT) Figure 5. Aluminum Adjuvant Image Figure 6. Global Aluminum Adjuvant Sales YoY Growth (2021-2032) & (MT) Figure 7. Emulsions Adjuvant Image Figure 8. Global Emulsions Adjuvant Sales YoY Growth (2021-2032) & (MT) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (MT) Figure 11. Global Vaccine Adjuvants Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Vaccine Adjuvants Market Share by Type 2025 VS 2032 Figure 13. North America Vaccine Adjuvants Sales Market Share in Volume by Type in 2025 Figure 14. North America Vaccine Adjuvants Sales Market Share in Value by Type in 2025 Figure 15. Europe Vaccine Adjuvants Sales Market Share in Volume by Type in 2025 Figure 16. Europe Vaccine Adjuvants Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Vaccine Adjuvants Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Vaccine Adjuvants Sales Market Share in Value by Type in 2025 Figure 19. Latin America Vaccine Adjuvants Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Vaccine Adjuvants Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Vaccine Adjuvants Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Vaccine Adjuvants Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Vaccine Adjuvants Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Human Vaccine Image Figure 26. Global Human Vaccine Sales YoY Growth (2021-2032) & (MT) Figure 27. Veterinary Vaccine Image Figure 28. Global Veterinary Vaccine Sales YoY Growth (2021-2032) & (MT) Figure 29. Global Vaccine Adjuvants Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Vaccine Adjuvants Market Share by Application 2025 VS 2032 Figure 31. North America Vaccine Adjuvants Sales Market Share in Volume by Application in 2025 Figure 32. North America Vaccine Adjuvants Sales Market Share in Value by Application in 2025 Figure 33. Europe Vaccine Adjuvants Sales Market Share in Volume by Application in 2025 Figure 34. Europe Vaccine Adjuvants Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Vaccine Adjuvants Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Vaccine Adjuvants Sales Market Share in Value by Application in 2025 Figure 37. Latin America Vaccine Adjuvants Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Vaccine Adjuvants Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Vaccine Adjuvants Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Vaccine Adjuvants Sales Market Share in Value by Application in 2025 Figure 41. North America Vaccine Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 42. North America Vaccine Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Vaccine Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Vaccine Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 46. Europe Vaccine Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Vaccine Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Vaccine Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 50. Asia-Pacific Vaccine Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Vaccine Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Vaccine Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 54. Latin America Vaccine Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Vaccine Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Vaccine Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 58. Middle East and Africa Vaccine Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Vaccine Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Vaccine Adjuvants Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Vaccine Adjuvants Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Aluminum Adjuvant
  • Emulsions Adjuvant
  • Others
Applications
  • Human Vaccine
  • Veterinary Vaccine
Companies covered
  • GSK
  • CSL Limited
  • Croda
  • SEPPIC
  • Novavax
  • SPI Pharma
  • Phibro
  • SDA BIO
  • Invivogen
  • Tj Kaiwei
  • OZ Biosciences
  • Brenntag Biosector
  • MVP Laboratories
  • Zhuoyue
  • Aphios

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vaccine Adjuvants Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Vaccine Adjuvants Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Vaccine Adjuvants Market by Type
  6. 1.3.1 Aluminum Adjuvant
  7. 1.3.2 Emulsions Adjuvant
  8. 1.3.3 Others
  9. 1.4 Global Vaccine Adjuvants Market Size by Type
  10. 1.4.1 Global Vaccine Adjuvants Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Vaccine Adjuvants Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Vaccine Adjuvants Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Vaccine Adjuvants Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Vaccine Adjuvants Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Vaccine Adjuvants Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Vaccine Adjuvants Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Vaccine Adjuvants Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Vaccine Adjuvants Industry Trends
  2. 2.2 Vaccine Adjuvants Industry Drivers
  3. 2.3 Vaccine Adjuvants Industry Opportunities and Challenges
  4. 2.4 Vaccine Adjuvants Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Vaccine Adjuvants Revenue (2021-2026)
  2. 3.2 Global Top Players by Vaccine Adjuvants Sales (2021-2026)
  3. 3.3 Global Top Players by Vaccine Adjuvants Price (2021-2026)
  4. 3.4 Global Vaccine Adjuvants Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vaccine Adjuvants Major Company Production Sites & Headquarters
  6. 3.6 Global Vaccine Adjuvants Company, Product Type & Application
  7. 3.7 Global Vaccine Adjuvants Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vaccine Adjuvants Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vaccine Adjuvants Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vaccine Adjuvants Tier 1, Tier 2, and Tier 3
4 Vaccine Adjuvants Regional Status and Outlook
  1. 4.1 Global Vaccine Adjuvants Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Vaccine Adjuvants Historic Market Size by Region
  3. 4.2.1 Global Vaccine Adjuvants Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Vaccine Adjuvants Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Vaccine Adjuvants Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Vaccine Adjuvants Forecasted Market Size by Region
  7. 4.3.1 Global Vaccine Adjuvants Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Vaccine Adjuvants Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Vaccine Adjuvants Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Vaccine Adjuvants by Application
  1. 5.1 Vaccine Adjuvants Market by Application
  2. 5.1.1 Human Vaccine
  3. 5.1.2 Veterinary Vaccine
  4. 5.2 Global Vaccine Adjuvants Market Size by Application
  5. 5.2.1 Global Vaccine Adjuvants Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Vaccine Adjuvants Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Vaccine Adjuvants Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Vaccine Adjuvants Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Vaccine Adjuvants Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Vaccine Adjuvants Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Vaccine Adjuvants Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Vaccine Adjuvants Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Vaccine Adjuvants Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 CSL Limited
  8. 6.2.1 CSL Limited Company Information
  9. 6.2.2 CSL Limited Business Overview
  10. 6.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSL Limited Vaccine Adjuvants Product Portfolio
  12. 6.2.5 CSL Limited Recent Developments
  13. 6.3 Croda
  14. 6.3.1 Croda Company Information
  15. 6.3.2 Croda Business Overview
  16. 6.3.3 Croda Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Croda Vaccine Adjuvants Product Portfolio
  18. 6.3.5 Croda Recent Developments
  19. 6.4 SEPPIC
  20. 6.4.1 SEPPIC Company Information
  21. 6.4.2 SEPPIC Business Overview
  22. 6.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 SEPPIC Vaccine Adjuvants Product Portfolio
  24. 6.4.5 SEPPIC Recent Developments
  25. 6.5 Novavax
  26. 6.5.1 Novavax Company Information
  27. 6.5.2 Novavax Business Overview
  28. 6.5.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novavax Vaccine Adjuvants Product Portfolio
  30. 6.5.5 Novavax Recent Developments
  31. 6.6 SPI Pharma
  32. 6.6.1 SPI Pharma Company Information
  33. 6.6.2 SPI Pharma Business Overview
  34. 6.6.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 SPI Pharma Vaccine Adjuvants Product Portfolio
  36. 6.6.5 SPI Pharma Recent Developments
  37. 6.7 Phibro
  38. 6.7.1 Phibro Company Information
  39. 6.7.2 Phibro Business Overview
  40. 6.7.3 Phibro Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Phibro Vaccine Adjuvants Product Portfolio
  42. 6.7.5 Phibro Recent Developments
  43. 6.8 SDA BIO
  44. 6.8.1 SDA BIO Company Information
  45. 6.8.2 SDA BIO Business Overview
  46. 6.8.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 SDA BIO Vaccine Adjuvants Product Portfolio
  48. 6.8.5 SDA BIO Recent Developments
  49. 6.9 Invivogen
  50. 6.9.1 Invivogen Company Information
  51. 6.9.2 Invivogen Business Overview
  52. 6.9.3 Invivogen Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Invivogen Vaccine Adjuvants Product Portfolio
  54. 6.9.5 Invivogen Recent Developments
  55. 6.10 Tj Kaiwei
  56. 6.10.1 Tj Kaiwei Company Information
  57. 6.10.2 Tj Kaiwei Business Overview
  58. 6.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Tj Kaiwei Vaccine Adjuvants Product Portfolio
  60. 6.10.5 Tj Kaiwei Recent Developments
  61. 6.11 OZ Biosciences
  62. 6.11.1 OZ Biosciences Company Information
  63. 6.11.2 OZ Biosciences Business Overview
  64. 6.11.3 OZ Biosciences Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 OZ Biosciences Vaccine Adjuvants Product Portfolio
  66. 6.11.5 OZ Biosciences Recent Developments
  67. 6.12 Brenntag Biosector
  68. 6.12.1 Brenntag Biosector Company Information
  69. 6.12.2 Brenntag Biosector Business Overview
  70. 6.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Brenntag Biosector Vaccine Adjuvants Product Portfolio
  72. 6.12.5 Brenntag Biosector Recent Developments
  73. 6.13 MVP Laboratories
  74. 6.13.1 MVP Laboratories Company Information
  75. 6.13.2 MVP Laboratories Business Overview
  76. 6.13.3 MVP Laboratories Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 MVP Laboratories Vaccine Adjuvants Product Portfolio
  78. 6.13.5 MVP Laboratories Recent Developments
  79. 6.14 Zhuoyue
  80. 6.14.1 Zhuoyue Company Information
  81. 6.14.2 Zhuoyue Business Overview
  82. 6.14.3 Zhuoyue Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Zhuoyue Vaccine Adjuvants Product Portfolio
  84. 6.14.5 Zhuoyue Recent Developments
  85. 6.15 Aphios
  86. 6.15.1 Aphios Company Information
  87. 6.15.2 Aphios Business Overview
  88. 6.15.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Aphios Vaccine Adjuvants Product Portfolio
  90. 6.15.5 Aphios Recent Developments
7 North America by Country
  1. 7.1 North America Vaccine Adjuvants Sales by Country
  2. 7.1.1 North America Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Vaccine Adjuvants Sales by Country (2021-2026)
  4. 7.1.3 North America Vaccine Adjuvants Sales Forecast by Country (2027-2032)
  5. 7.2 North America Vaccine Adjuvants Market Size by Country
  6. 7.2.1 North America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Vaccine Adjuvants Market Size by Country (2021-2026)
  8. 7.2.3 North America Vaccine Adjuvants Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Vaccine Adjuvants Sales by Country
  2. 8.1.1 Europe Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Vaccine Adjuvants Sales by Country (2021-2026)
  4. 8.1.3 Europe Vaccine Adjuvants Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Vaccine Adjuvants Market Size by Country
  6. 8.2.1 Europe Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Vaccine Adjuvants Market Size by Country (2021-2026)
  8. 8.2.3 Europe Vaccine Adjuvants Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Vaccine Adjuvants Sales by Country
  2. 9.1.1 Asia-Pacific Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Vaccine Adjuvants Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Vaccine Adjuvants Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Vaccine Adjuvants Market Size by Country
  6. 9.2.1 Asia-Pacific Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Vaccine Adjuvants Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Vaccine Adjuvants Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Vaccine Adjuvants Sales by Country
  2. 10.1.1 South America Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Vaccine Adjuvants Sales by Country (2021-2026)
  4. 10.1.3 South America Vaccine Adjuvants Sales Forecast by Country (2027-2032)
  5. 10.2 South America Vaccine Adjuvants Market Size by Country
  6. 10.2.1 South America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Vaccine Adjuvants Market Size by Country (2021-2026)
  8. 10.2.3 South America Vaccine Adjuvants Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Vaccine Adjuvants Sales by Country
  2. 11.1.1 Middle East and Africa Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Vaccine Adjuvants Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Vaccine Adjuvants Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Vaccine Adjuvants Market Size by Country
  6. 11.2.1 Middle East and Africa Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Vaccine Adjuvants Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Vaccine Adjuvants Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Vaccine Adjuvants Value Chain Analysis
  2. 12.1.1 Vaccine Adjuvants Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Vaccine Adjuvants Production Mode & Process
  7. 12.2 Vaccine Adjuvants Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Vaccine Adjuvants Distributors
  10. 12.2.3 Vaccine Adjuvants Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst